147 related articles for article (PubMed ID: 37811283)
1. Retracted: lncRNA NUTM2A-AS1 Targets the SRSF1/Trim37 Signaling Pathway to Promote the Proliferation and Invasion of Breast Cancer.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9895079. PubMed ID: 37811283
[TBL] [Abstract][Full Text] [Related]
2. lncRNA NUTM2A-AS1 Targets the SRSF1/Trim37 Signaling Pathway to Promote the Proliferation and Invasion of Breast Cancer.
Ning X; Zhao J; He F; Yuan Y; Li B; Ruan J
Comput Math Methods Med; 2022; 2022():3299336. PubMed ID: 35959349
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NUTM2A-AS1 positively modulates TET1 and HIF-1A to enhance gastric cancer tumorigenesis and drug resistance by sponging miR-376a.
Wang J; Yu Z; Wang J; Shen Y; Qiu J; Zhuang Z
Cancer Med; 2020 Dec; 9(24):9499-9510. PubMed ID: 33089970
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lncRNA NUTM2A-AS1 inhibits lung adenocarcinoma cell viability by regulating the miR-590-5p/METTL3 axis.
Wang J; Zha J; Wang X
Oncol Lett; 2021 Nov; 22(5):798. PubMed ID: 34630705
[TBL] [Abstract][Full Text] [Related]
6. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.
Fu T; Ji K; Jin L; Zhang J; Wu X; Ji X; Fan B; Jia Z; Wang A; Liu J; Bu Z; Ji J
Gastric Cancer; 2021 Jan; 24(1):45-59. PubMed ID: 32572790
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9854591. PubMed ID: 37811245
[TBL] [Abstract][Full Text] [Related]
8. NUTM2A-AS1 silencing alleviates LPS-induced apoptosis and inflammation in dental pulp cells through targeting let-7c-5p/HMGB1 axis.
Wang X; Sun H; Hu Z; Mei P; Wu Y; Zhu M
Int Immunopharmacol; 2021 Jul; 96():107497. PubMed ID: 33831808
[TBL] [Abstract][Full Text] [Related]
9. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
Nong Q; Yu S; Hu H; Hu X
Comput Math Methods Med; 2021; 2021():9674761. PubMed ID: 34873418
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA TMPO-AS1 facilitates chemoresistance and invasion in breast cancer by modulating the miR-1179/TRIM37 axis.
Ning X; Zhao J; He F; Yuan Y; Li B; Ruan J
Oncol Lett; 2021 Jul; 22(1):500. PubMed ID: 33981362
[TBL] [Abstract][Full Text] [Related]
12. LncRNA GASAL1 Interacts with SRSF1 to Regulate Trophoblast Cell Proliferation, Invasion, and Apoptosis Via the mTOR Signaling Pathway.
Liu J; Zhang Q; Ma N
Cell Transplant; 2020; 29():963689720965182. PubMed ID: 33028104
[TBL] [Abstract][Full Text] [Related]
13. Retracted: lncRNA MSC-AS1/miRNA-429 Axis Mediates Growth and Metastasis of Nasopharyngeal Carcinoma via JAK1/STAT3 Signaling Pathway.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9768312. PubMed ID: 38077908
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2.
Liu M; Gou L; Xia J; Wan Q; Jiang Y; Sun S; Tang M; He T; Zhang Y
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29941860
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway.
Di S; Bai R; Lu D; Chen C; Ma T; Zou Z; Zhang Z
Cell Death Discov; 2022 May; 8(1):249. PubMed ID: 35513366
[TBL] [Abstract][Full Text] [Related]
16. Long-Chain Non-Coding SOX21-AS1 Promotes Proliferation and Migration of Breast Cancer Cells Through the PI3K/AKT Signaling Pathway.
Sheng XY; Wang CH; Wang CF; Xu HY
Cancer Manag Res; 2020; 12():11005-11014. PubMed ID: 33173334
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y
Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638
[TBL] [Abstract][Full Text] [Related]
19. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
[TBL] [Abstract][Full Text] [Related]
20. Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9859381. PubMed ID: 37811306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
